Global Anti-Migraine Drugs Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Anti-Migraine Drugs Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Anti-Migraine Drugs by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Anti-Migraine Drugs by Country/Region, 2017, 2022 & 2028

2.2 Anti-Migraine Drugs Segment by Type

2.2.1 Triptans

2.2.2 Ergots

2.2.3 Others

2.3 Anti-Migraine Drugs Sales by Type

2.3.1 Global Anti-Migraine Drugs Sales Market Share by Type (2017-2022)

2.3.2 Global Anti-Migraine Drugs Revenue and Market Share by Type (2017-2022)

2.3.3 Global Anti-Migraine Drugs Sale Price by Type (2017-2022)

2.4 Anti-Migraine Drugs Segment by Application

2.4.1 Women

2.4.2 Men

2.5 Anti-Migraine Drugs Sales by Application

2.5.1 Global Anti-Migraine Drugs Sale Market Share by Application (2017-2022)

2.5.2 Global Anti-Migraine Drugs Revenue and Market Share by Application (2017-2022)

2.5.3 Global Anti-Migraine Drugs Sale Price by Application (2017-2022)

3 Global Anti-Migraine Drugs by Company

3.1 Global Anti-Migraine Drugs Breakdown Data by Company

3.1.1 Global Anti-Migraine Drugs Annual Sales by Company (2020-2022)

3.1.2 Global Anti-Migraine Drugs Sales Market Share by Company (2020-2022)

3.2 Global Anti-Migraine Drugs Annual Revenue by Company (2020-2022)

3.2.1 Global Anti-Migraine Drugs Revenue by Company (2020-2022)

3.2.2 Global Anti-Migraine Drugs Revenue Market Share by Company (2020-2022)

3.3 Global Anti-Migraine Drugs Sale Price by Company

3.4 Key Manufacturers Anti-Migraine Drugs Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Anti-Migraine Drugs Product Location Distribution

3.4.2 Players Anti-Migraine Drugs Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Anti-Migraine Drugs by Geographic Region

4.1 World Historic Anti-Migraine Drugs Market Size by Geographic Region (2017-2022)

4.1.1 Global Anti-Migraine Drugs Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Anti-Migraine Drugs Annual Revenue by Geographic Region

4.2 World Historic Anti-Migraine Drugs Market Size by Country/Region (2017-2022)

4.2.1 Global Anti-Migraine Drugs Annual Sales by Country/Region (2017-2022)

4.2.2 Global Anti-Migraine Drugs Annual Revenue by Country/Region

4.3 Americas Anti-Migraine Drugs Sales Growth

4.4 APAC Anti-Migraine Drugs Sales Growth

4.5 Europe Anti-Migraine Drugs Sales Growth

4.6 Middle East & Africa Anti-Migraine Drugs Sales Growth

5 Americas

5.1 Americas Anti-Migraine Drugs Sales by Country

5.1.1 Americas Anti-Migraine Drugs Sales by Country (2017-2022)

5.1.2 Americas Anti-Migraine Drugs Revenue by Country (2017-2022)

5.2 Americas Anti-Migraine Drugs Sales by Type

5.3 Americas Anti-Migraine Drugs Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Anti-Migraine Drugs Sales by Region

6.1.1 APAC Anti-Migraine Drugs Sales by Region (2017-2022)

6.1.2 APAC Anti-Migraine Drugs Revenue by Region (2017-2022)

6.2 APAC Anti-Migraine Drugs Sales by Type

6.3 APAC Anti-Migraine Drugs Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Anti-Migraine Drugs by Country

7.1.1 Europe Anti-Migraine Drugs Sales by Country (2017-2022)

7.1.2 Europe Anti-Migraine Drugs Revenue by Country (2017-2022)

7.2 Europe Anti-Migraine Drugs Sales by Type

7.3 Europe Anti-Migraine Drugs Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Anti-Migraine Drugs by Country

8.1.1 Middle East & Africa Anti-Migraine Drugs Sales by Country (2017-2022)

8.1.2 Middle East & Africa Anti-Migraine Drugs Revenue by Country (2017-2022)

8.2 Middle East & Africa Anti-Migraine Drugs Sales by Type

8.3 Middle East & Africa Anti-Migraine Drugs Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Anti-Migraine Drugs

10.3 Manufacturing Process Analysis of Anti-Migraine Drugs

10.4 Industry Chain Structure of Anti-Migraine Drugs

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Anti-Migraine Drugs Distributors

11.3 Anti-Migraine Drugs Customer

12 World Forecast Review for Anti-Migraine Drugs by Geographic Region

12.1 Global Anti-Migraine Drugs Market Size Forecast by Region

12.1.1 Global Anti-Migraine Drugs Forecast by Region (2023-2028)

12.1.2 Global Anti-Migraine Drugs Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Anti-Migraine Drugs Forecast by Type

12.7 Global Anti-Migraine Drugs Forecast by Application

13 Key Players Analysis

13.1 Eli Lilly

13.1.1 Eli Lilly Company Information

13.1.2 Eli Lilly Anti-Migraine Drugs Product Offered

13.1.3 Eli Lilly Anti-Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Eli Lilly Main Business Overview

13.1.5 Eli Lilly Latest Developments

13.2 Abbott

13.2.1 Abbott Company Information

13.2.2 Abbott Anti-Migraine Drugs Product Offered

13.2.3 Abbott Anti-Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Abbott Main Business Overview

13.2.5 Abbott Latest Developments

13.3 Eisai

13.3.1 Eisai Company Information

13.3.2 Eisai Anti-Migraine Drugs Product Offered

13.3.3 Eisai Anti-Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Eisai Main Business Overview

13.3.5 Eisai Latest Developments

13.4 Allergan

13.4.1 Allergan Company Information

13.4.2 Allergan Anti-Migraine Drugs Product Offered

13.4.3 Allergan Anti-Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Allergan Main Business Overview

13.4.5 Allergan Latest Developments

13.5 Endo

13.5.1 Endo Company Information

13.5.2 Endo Anti-Migraine Drugs Product Offered

13.5.3 Endo Anti-Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Endo Main Business Overview

13.5.5 Endo Latest Developments

13.6 GlaxoSmithKline

13.6.1 GlaxoSmithKline Company Information

13.6.2 GlaxoSmithKline Anti-Migraine Drugs Product Offered

13.6.3 GlaxoSmithKline Anti-Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 GlaxoSmithKline Main Business Overview

13.6.5 GlaxoSmithKline Latest Developments

13.7 Impax Laboratories

13.7.1 Impax Laboratories Company Information

13.7.2 Impax Laboratories Anti-Migraine Drugs Product Offered

13.7.3 Impax Laboratories Anti-Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Impax Laboratories Main Business Overview

13.7.5 Impax Laboratories Latest Developments

13.8 Pfizer

13.8.1 Pfizer Company Information

13.8.2 Pfizer Anti-Migraine Drugs Product Offered

13.8.3 Pfizer Anti-Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Pfizer Main Business Overview

13.8.5 Pfizer Latest Developments

13.9 AstraZeneca

13.9.1 AstraZeneca Company Information

13.9.2 AstraZeneca Anti-Migraine Drugs Product Offered

13.9.3 AstraZeneca Anti-Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 AstraZeneca Main Business Overview

13.9.5 AstraZeneca Latest Developments

13.10 Bayer

13.10.1 Bayer Company Information

13.10.2 Bayer Anti-Migraine Drugs Product Offered

13.10.3 Bayer Anti-Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Bayer Main Business Overview

13.10.5 Bayer Latest Developments

13.11 Johnson & Johnson

13.11.1 Johnson & Johnson Company Information

13.11.2 Johnson & Johnson Anti-Migraine Drugs Product Offered

13.11.3 Johnson & Johnson Anti-Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Johnson & Johnson Main Business Overview

13.11.5 Johnson & Johnson Latest Developments

13.12 Merck

13.12.1 Merck Company Information

13.12.2 Merck Anti-Migraine Drugs Product Offered

13.12.3 Merck Anti-Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Merck Main Business Overview

13.12.5 Merck Latest Developments

13.13 Teva

13.13.1 Teva Company Information

13.13.2 Teva Anti-Migraine Drugs Product Offered

13.13.3 Teva Anti-Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Teva Main Business Overview

13.13.5 Teva Latest Developments

13.14 Amgen

13.14.1 Amgen Company Information

13.14.2 Amgen Anti-Migraine Drugs Product Offered

13.14.3 Amgen Anti-Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Amgen Main Business Overview

13.14.5 Amgen Latest Developments

14 Research Findings and Conclusion

Table 1. Anti-Migraine Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Anti-Migraine Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Triptans

Table 4. Major Players of Ergots

Table 5. Major Players of Others

Table 6. Global Anti-Migraine Drugs Sales by Type (2017-2022) & (K Units)

Table 7. Global Anti-Migraine Drugs Sales Market Share by Type (2017-2022)

Table 8. Global Anti-Migraine Drugs Revenue by Type (2017-2022) & ($ million)

Table 9. Global Anti-Migraine Drugs Revenue Market Share by Type (2017-2022)

Table 10. Global Anti-Migraine Drugs Sale Price by Type (2017-2022) & (USD/Pcs)

Table 11. Global Anti-Migraine Drugs Sales by Application (2017-2022) & (K Units)

Table 12. Global Anti-Migraine Drugs Sales Market Share by Application (2017-2022)

Table 13. Global Anti-Migraine Drugs Revenue by Application (2017-2022)

Table 14. Global Anti-Migraine Drugs Revenue Market Share by Application (2017-2022)

Table 15. Global Anti-Migraine Drugs Sale Price by Application (2017-2022) & (USD/Pcs)

Table 16. Global Anti-Migraine Drugs Sales by Company (2020-2022) & (K Units)

Table 17. Global Anti-Migraine Drugs Sales Market Share by Company (2020-2022)

Table 18. Global Anti-Migraine Drugs Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Anti-Migraine Drugs Revenue Market Share by Company (2020-2022)

Table 20. Global Anti-Migraine Drugs Sale Price by Company (2020-2022) & (USD/Pcs)

Table 21. Key Manufacturers Anti-Migraine Drugs Producing Area Distribution and Sales Area

Table 22. Players Anti-Migraine Drugs Products Offered

Table 23. Anti-Migraine Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Anti-Migraine Drugs Sales by Geographic Region (2017-2022) & (K Units)

Table 27. Global Anti-Migraine Drugs Sales Market Share Geographic Region (2017-2022)

Table 28. Global Anti-Migraine Drugs Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Anti-Migraine Drugs Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Anti-Migraine Drugs Sales by Country/Region (2017-2022) & (K Units)

Table 31. Global Anti-Migraine Drugs Sales Market Share by Country/Region (2017-2022)

Table 32. Global Anti-Migraine Drugs Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Anti-Migraine Drugs Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Anti-Migraine Drugs Sales by Country (2017-2022) & (K Units)

Table 35. Americas Anti-Migraine Drugs Sales Market Share by Country (2017-2022)

Table 36. Americas Anti-Migraine Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Anti-Migraine Drugs Revenue Market Share by Country (2017-2022)

Table 38. Americas Anti-Migraine Drugs Sales by Type (2017-2022) & (K Units)

Table 39. Americas Anti-Migraine Drugs Sales Market Share by Type (2017-2022)

Table 40. Americas Anti-Migraine Drugs Sales by Application (2017-2022) & (K Units)

Table 41. Americas Anti-Migraine Drugs Sales Market Share by Application (2017-2022)

Table 42. APAC Anti-Migraine Drugs Sales by Region (2017-2022) & (K Units)

Table 43. APAC Anti-Migraine Drugs Sales Market Share by Region (2017-2022)

Table 44. APAC Anti-Migraine Drugs Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Anti-Migraine Drugs Revenue Market Share by Region (2017-2022)

Table 46. APAC Anti-Migraine Drugs Sales by Type (2017-2022) & (K Units)

Table 47. APAC Anti-Migraine Drugs Sales Market Share by Type (2017-2022)

Table 48. APAC Anti-Migraine Drugs Sales by Application (2017-2022) & (K Units)

Table 49. APAC Anti-Migraine Drugs Sales Market Share by Application (2017-2022)

Table 50. Europe Anti-Migraine Drugs Sales by Country (2017-2022) & (K Units)

Table 51. Europe Anti-Migraine Drugs Sales Market Share by Country (2017-2022)

Table 52. Europe Anti-Migraine Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Anti-Migraine Drugs Revenue Market Share by Country (2017-2022)

Table 54. Europe Anti-Migraine Drugs Sales by Type (2017-2022) & (K Units)

Table 55. Europe Anti-Migraine Drugs Sales Market Share by Type (2017-2022)

Table 56. Europe Anti-Migraine Drugs Sales by Application (2017-2022) & (K Units)

Table 57. Europe Anti-Migraine Drugs Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Anti-Migraine Drugs Sales by Country (2017-2022) & (K Units)

Table 59. Middle East & Africa Anti-Migraine Drugs Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Anti-Migraine Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Anti-Migraine Drugs Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Anti-Migraine Drugs Sales by Type (2017-2022) & (K Units)

Table 63. Middle East & Africa Anti-Migraine Drugs Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Anti-Migraine Drugs Sales by Application (2017-2022) & (K Units)

Table 65. Middle East & Africa Anti-Migraine Drugs Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Anti-Migraine Drugs

Table 67. Key Market Challenges & Risks of Anti-Migraine Drugs

Table 68. Key Industry Trends of Anti-Migraine Drugs

Table 69. Anti-Migraine Drugs Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Anti-Migraine Drugs Distributors List

Table 72. Anti-Migraine Drugs Customer List

Table 73. Global Anti-Migraine Drugs Sales Forecast by Region (2023-2028) & (K Units)

Table 74. Global Anti-Migraine Drugs Sales Market Forecast by Region

Table 75. Global Anti-Migraine Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Anti-Migraine Drugs Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Anti-Migraine Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 78. Americas Anti-Migraine Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Anti-Migraine Drugs Sales Forecast by Region (2023-2028) & (K Units)

Table 80. APAC Anti-Migraine Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Anti-Migraine Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 82. Europe Anti-Migraine Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Anti-Migraine Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Middle East & Africa Anti-Migraine Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Anti-Migraine Drugs Sales Forecast by Type (2023-2028) & (K Units)

Table 86. Global Anti-Migraine Drugs Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Anti-Migraine Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Anti-Migraine Drugs Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Anti-Migraine Drugs Sales Forecast by Application (2023-2028) & (K Units)

Table 90. Global Anti-Migraine Drugs Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Anti-Migraine Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Anti-Migraine Drugs Revenue Market Share Forecast by Application (2023-2028)

Table 93. Eli Lilly Basic Information, Anti-Migraine Drugs Manufacturing Base, Sales Area and Its Competitors

Table 94. Eli Lilly Anti-Migraine Drugs Product Offered

Table 95. Eli Lilly Anti-Migraine Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 96. Eli Lilly Main Business

Table 97. Eli Lilly Latest Developments

Table 98. Abbott Basic Information, Anti-Migraine Drugs Manufacturing Base, Sales Area and Its Competitors

Table 99. Abbott Anti-Migraine Drugs Product Offered

Table 100. Abbott Anti-Migraine Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 101. Abbott Main Business

Table 102. Abbott Latest Developments

Table 103. Eisai Basic Information, Anti-Migraine Drugs Manufacturing Base, Sales Area and Its Competitors

Table 104. Eisai Anti-Migraine Drugs Product Offered

Table 105. Eisai Anti-Migraine Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 106. Eisai Main Business

Table 107. Eisai Latest Developments

Table 108. Allergan Basic Information, Anti-Migraine Drugs Manufacturing Base, Sales Area and Its Competitors

Table 109. Allergan Anti-Migraine Drugs Product Offered

Table 110. Allergan Anti-Migraine Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 111. Allergan Main Business

Table 112. Allergan Latest Developments

Table 113. Endo Basic Information, Anti-Migraine Drugs Manufacturing Base, Sales Area and Its Competitors

Table 114. Endo Anti-Migraine Drugs Product Offered

Table 115. Endo Anti-Migraine Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 116. Endo Main Business

Table 117. Endo Latest Developments

Table 118. GlaxoSmithKline Basic Information, Anti-Migraine Drugs Manufacturing Base, Sales Area and Its Competitors

Table 119. GlaxoSmithKline Anti-Migraine Drugs Product Offered

Table 120. GlaxoSmithKline Anti-Migraine Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 121. GlaxoSmithKline Main Business

Table 122. GlaxoSmithKline Latest Developments

Table 123. Impax Laboratories Basic Information, Anti-Migraine Drugs Manufacturing Base, Sales Area and Its Competitors

Table 124. Impax Laboratories Anti-Migraine Drugs Product Offered

Table 125. Impax Laboratories Anti-Migraine Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 126. Impax Laboratories Main Business

Table 127. Impax Laboratories Latest Developments

Table 128. Pfizer Basic Information, Anti-Migraine Drugs Manufacturing Base, Sales Area and Its Competitors

Table 129. Pfizer Anti-Migraine Drugs Product Offered

Table 130. Pfizer Anti-Migraine Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 131. Pfizer Main Business

Table 132. Pfizer Latest Developments

Table 133. AstraZeneca Basic Information, Anti-Migraine Drugs Manufacturing Base, Sales Area and Its Competitors

Table 134. AstraZeneca Anti-Migraine Drugs Product Offered

Table 135. AstraZeneca Anti-Migraine Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 136. AstraZeneca Main Business

Table 137. AstraZeneca Latest Developments

Table 138. Bayer Basic Information, Anti-Migraine Drugs Manufacturing Base, Sales Area and Its Competitors

Table 139. Bayer Anti-Migraine Drugs Product Offered

Table 140. Bayer Anti-Migraine Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 141. Bayer Main Business

Table 142. Bayer Latest Developments

Table 143. Johnson & Johnson Basic Information, Anti-Migraine Drugs Manufacturing Base, Sales Area and Its Competitors

Table 144. Johnson & Johnson Anti-Migraine Drugs Product Offered

Table 145. Johnson & Johnson Anti-Migraine Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 146. Johnson & Johnson Main Business

Table 147. Johnson & Johnson Latest Developments

Table 148. Merck Basic Information, Anti-Migraine Drugs Manufacturing Base, Sales Area and Its Competitors

Table 149. Merck Anti-Migraine Drugs Product Offered

Table 150. Merck Anti-Migraine Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 151. Merck Main Business

Table 152. Merck Latest Developments

Table 153. Teva Basic Information, Anti-Migraine Drugs Manufacturing Base, Sales Area and Its Competitors

Table 154. Teva Anti-Migraine Drugs Product Offered

Table 155. Teva Anti-Migraine Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 156. Teva Main Business

Table 157. Teva Latest Developments

Table 158. Amgen Basic Information, Anti-Migraine Drugs Manufacturing Base, Sales Area and Its Competitors

Table 159. Amgen Anti-Migraine Drugs Product Offered

Table 160. Amgen Anti-Migraine Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 161. Amgen Main Business

Table 162. Amgen Latest Developments

List of Figures

Figure 1. Picture of Anti-Migraine Drugs

Figure 2. Anti-Migraine Drugs Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Anti-Migraine Drugs Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Anti-Migraine Drugs Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Anti-Migraine Drugs Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Triptans

Figure 10. Product Picture of Ergots

Figure 11. Product Picture of Others

Figure 12. Global Anti-Migraine Drugs Sales Market Share by Type in 2021

Figure 13. Global Anti-Migraine Drugs Revenue Market Share by Type (2017-2022)

Figure 14. Anti-Migraine Drugs Consumed in Women

Figure 15. Global Anti-Migraine Drugs Market: Women (2017-2022) & (K Units)

Figure 16. Anti-Migraine Drugs Consumed in Men

Figure 17. Global Anti-Migraine Drugs Market: Men (2017-2022) & (K Units)

Figure 18. Global Anti-Migraine Drugs Sales Market Share by Application (2017-2022)

Figure 19. Global Anti-Migraine Drugs Revenue Market Share by Application in 2021

Figure 20. Anti-Migraine Drugs Revenue Market by Company in 2021 ($ Million)

Figure 21. Global Anti-Migraine Drugs Revenue Market Share by Company in 2021

Figure 22. Global Anti-Migraine Drugs Sales Market Share by Geographic Region (2017-2022)

Figure 23. Global Anti-Migraine Drugs Revenue Market Share by Geographic Region in 2021

Figure 24. Global Anti-Migraine Drugs Sales Market Share by Region (2017-2022)

Figure 25. Global Anti-Migraine Drugs Revenue Market Share by Country/Region in 2021

Figure 26. Americas Anti-Migraine Drugs Sales 2017-2022 (K Units)

Figure 27. Americas Anti-Migraine Drugs Revenue 2017-2022 ($ Millions)

Figure 28. APAC Anti-Migraine Drugs Sales 2017-2022 (K Units)

Figure 29. APAC Anti-Migraine Drugs Revenue 2017-2022 ($ Millions)

Figure 30. Europe Anti-Migraine Drugs Sales 2017-2022 (K Units)

Figure 31. Europe Anti-Migraine Drugs Revenue 2017-2022 ($ Millions)

Figure 32. Middle East & Africa Anti-Migraine Drugs Sales 2017-2022 (K Units)

Figure 33. Middle East & Africa Anti-Migraine Drugs Revenue 2017-2022 ($ Millions)

Figure 34. Americas Anti-Migraine Drugs Sales Market Share by Country in 2021

Figure 35. Americas Anti-Migraine Drugs Revenue Market Share by Country in 2021

Figure 36. United States Anti-Migraine Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 37. Canada Anti-Migraine Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 38. Mexico Anti-Migraine Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 39. Brazil Anti-Migraine Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 40. APAC Anti-Migraine Drugs Sales Market Share by Region in 2021

Figure 41. APAC Anti-Migraine Drugs Revenue Market Share by Regions in 2021

Figure 42. China Anti-Migraine Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 43. Japan Anti-Migraine Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 44. South Korea Anti-Migraine Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 45. Southeast Asia Anti-Migraine Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 46. India Anti-Migraine Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 47. Australia Anti-Migraine Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 48. Europe Anti-Migraine Drugs Sales Market Share by Country in 2021

Figure 49. Europe Anti-Migraine Drugs Revenue Market Share by Country in 2021

Figure 50. Germany Anti-Migraine Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 51. France Anti-Migraine Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 52. UK Anti-Migraine Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 53. Italy Anti-Migraine Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 54. Russia Anti-Migraine Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 55. Middle East & Africa Anti-Migraine Drugs Sales Market Share by Country in 2021

Figure 56. Middle East & Africa Anti-Migraine Drugs Revenue Market Share by Country in 2021

Figure 57. Egypt Anti-Migraine Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 58. South Africa Anti-Migraine Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 59. Israel Anti-Migraine Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 60. Turkey Anti-Migraine Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 61. GCC Country Anti-Migraine Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 62. Manufacturing Cost Structure Analysis of Anti-Migraine Drugs in 2021

Figure 63. Manufacturing Process Analysis of Anti-Migraine Drugs

Figure 64. Industry Chain Structure of Anti-Migraine Drugs

Figure 65. Channels of Distribution

Figure 66. Distributors Profiles